Literature DB >> 7311886

Agglutination, toxigenicity and sorbitol fermentation of Clostridium difficile.

S Nakamura, T Serikawa, M Mikawa, S Nakashio, K Yamakawa, S Nishida.   

Abstract

A total of 79 Clostridium difficile strains from different sources (50 strains from the fecal specimens of healthy adults, 13 from patients receiving antibiotics without gastrointestinal complications, 13 from antibiotic-associated pseudomembranous colitis (PMC) or diarrhea patients, and three strains from ATCC) were investigated for agglutinability, using formol-treated cells as antigen, in relation to toxigenicity. C. difficile strains tested were divided into four serovars, I, II, III, and IV, by the cross-agglutination test. The agglutinin absorption test revealed that strains of serovar I, agglutinable with high titers (5,120-10,240) to antiserum prepared against a highly toxigenic C. difficile strain, ATCC 17859, possessed the serovar-specific antigen. All of the strains of serovar I were highly toxigenic and all 13 strains isolated from the fecal specimens of antibiotic-associated PMC or diarrhea patients belonged to this serovar, whereas 19 (38%) out of 50 strains from healthy adults and four (30.8%) out of 13 strains from patients receiving antibiotics without gastrointestinal complications possessed this antigen. None of the strains of other clostridial species than C. difficile were agglutinated by the three reference antisera used. Further study on the sugar fermentation test disclosed that sorbitol-fermenting property of C. difficile if very closely related to the toxigenicity and agglutinability.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7311886     DOI: 10.1111/j.1348-0421.1981.tb00091.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  8 in total

1.  Restriction endonuclease DNA analysis of Clostridium difficile.

Authors:  B W Wren; S Tabaqchali
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

2.  Immunoblotting to demonstrate antigenic and immunogenic differences among nine standard strains of Clostridium difficile.

Authors:  S R Heard; B Rasburn; R C Matthews; S Tabaqchali
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

3.  Correlation between susceptibility to chloramphenicol, tetracycline and clindamycin, and serogroups of Clostridium difficile.

Authors:  S Nakamura; K Yamakawa; S Nakashio; S Kamiya; S Nishida
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

4.  Molecular cloning and genetic analysis of a chloramphenicol acetyltransferase determinant from Clostridium difficile.

Authors:  B W Wren; P Mullany; C Clayton; S Tabaqchali
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

5.  Analysis of Clostridium difficile isolates from nosocomial outbreaks at three hospitals in diverse areas of Japan.

Authors:  H Kato; N Kato; K Watanabe; T Yamamoto; K Suzuki; S Ishigo; S Kunihiro; I Nakamura; G E Killgore; S Nakamura
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

6.  Serogrouping of Clostridium difficile strains by slide agglutination.

Authors:  M Delmee; M Homel; G Wauters
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

7.  Method for the typing of Clostridium difficile based on polyacrylamide gel electrophoresis of [35S]methionine-labeled proteins.

Authors:  S Tabaqchali; S O'Farrell; D Holland; R Silman
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

8.  A microbiota-generated bile salt induces biofilm formation in Clostridium difficile.

Authors:  Thomas Dubois; Yannick D N Tremblay; Audrey Hamiot; Isabelle Martin-Verstraete; Julien Deschamps; Marc Monot; Romain Briandet; Bruno Dupuy
Journal:  NPJ Biofilms Microbiomes       Date:  2019-05-09       Impact factor: 7.290

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.